Clinical utility of AQP4-IgG titers and measures of complement-mediated cell killing in NMOSD

OBJECTIVE: To investigate whether aquaporin-4–immunoglobulin G (AQP4-IgG) titers and measures of complement-mediated cell killing are clinically useful to predict the occurrence of relapse, relapse severity, and/or disability in neuromyelitis optica spectrum disorder (NMOSD). METHODS: We studied 336...

Descripción completa

Detalles Bibliográficos
Autores principales: Jitprapaikulsan, Jiraporn, Fryer, James P., Majed, Masoud, Smith, Carin Y., Jenkins, Sarah M., Cabre, Philippe, Hinson, Shannon R., Weinshenker, Brian G., Mandrekar, Jay, Chen, John J., Lucchinetti, Claudia F., Jiao, Yujuan, Segan, Jessica, Schmeling, John E., Mills, John, Flanagan, Eoin P., McKeon, Andrew, Pittock, Sean J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286655/
https://www.ncbi.nlm.nih.gov/pubmed/35413004
http://dx.doi.org/10.1212/NXI.0000000000000727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286655/
https://www.ncbi.nlm.nih.gov/pubmed/35413004
http://dx.doi.org/10.1212/NXI.0000000000000727

Ejemplares similares